averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
GATA3
|
ENSG00000107485.11 | GATA binding protein 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GATA3 | hg19_v2_chr10_+_8096631_8096660 | 0.06 | 3.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_139871948 | 34.12 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr7_+_142498725 | 31.40 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
chr2_-_89619904 | 30.20 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr2_-_89157161 | 27.24 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
chr2_-_89340242 | 26.56 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chrX_+_128913906 | 26.44 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chrX_+_38420623 | 25.71 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
chr2_-_89399845 | 25.35 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr2_+_89901292 | 24.43 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr2_+_90108504 | 24.26 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr2_-_89292422 | 23.19 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chrX_+_38420783 | 21.66 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr2_-_89513402 | 21.32 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr16_+_23847339 | 20.23 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr6_-_33041378 | 20.12 |
ENST00000428995.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr1_+_26644441 | 19.84 |
ENST00000374213.2
|
CD52
|
CD52 molecule |
chr2_-_89310012 | 19.76 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr6_+_33043703 | 19.75 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr11_-_5248294 | 19.46 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr12_-_11548496 | 19.18 |
ENST00000389362.4
ENST00000565533.1 ENST00000546254.1 |
PRB2
PRB1
|
proline-rich protein BstNI subfamily 2 proline-rich protein BstNI subfamily 1 |
chr12_-_11422630 | 18.86 |
ENST00000381842.3
ENST00000538488.1 |
PRB3
|
proline-rich protein BstNI subfamily 3 |
chr2_+_90139056 | 18.50 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr6_-_31514516 | 17.77 |
ENST00000303892.5
ENST00000483251.1 |
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
chr5_-_176056974 | 17.27 |
ENST00000510387.1
ENST00000506696.1 |
SNCB
|
synuclein, beta |
chr5_+_150404904 | 16.83 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
chr5_-_42825983 | 16.76 |
ENST00000506577.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chr2_-_89459813 | 16.29 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr22_+_23040274 | 16.18 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr19_+_5681011 | 16.14 |
ENST00000581893.1
ENST00000411793.2 ENST00000301382.4 ENST00000581773.1 ENST00000423665.2 ENST00000583928.1 ENST00000342970.2 ENST00000422535.2 ENST00000581521.1 ENST00000339423.2 |
HSD11B1L
|
hydroxysteroid (11-beta) dehydrogenase 1-like |
chr22_+_23241661 | 16.04 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr8_-_27457494 | 15.91 |
ENST00000521770.1
|
CLU
|
clusterin |
chr19_-_37701386 | 15.57 |
ENST00000527838.1
ENST00000591492.1 ENST00000532828.2 |
ZNF585B
|
zinc finger protein 585B |
chr22_-_38699003 | 15.51 |
ENST00000451964.1
|
CSNK1E
|
casein kinase 1, epsilon |
chr2_+_90198535 | 15.27 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr1_+_156123359 | 15.20 |
ENST00000368284.1
ENST00000368286.2 ENST00000438830.1 |
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr14_-_106209368 | 15.03 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr8_-_18871159 | 14.95 |
ENST00000327040.8
ENST00000440756.2 |
PSD3
|
pleckstrin and Sec7 domain containing 3 |
chr8_+_21911054 | 14.62 |
ENST00000519850.1
ENST00000381470.3 |
DMTN
|
dematin actin binding protein |
chr5_-_141338627 | 14.56 |
ENST00000231484.3
|
PCDH12
|
protocadherin 12 |
chr3_+_111718173 | 14.25 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
chr9_+_74526384 | 14.22 |
ENST00000334731.2
ENST00000377031.3 |
C9orf85
|
chromosome 9 open reading frame 85 |
chr3_-_195310802 | 14.12 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr22_+_23264766 | 13.99 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr22_-_21213029 | 13.93 |
ENST00000572273.1
ENST00000255882.6 |
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha |
chr16_+_23847267 | 13.88 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
chr19_-_49944806 | 13.75 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
chr2_-_89417335 | 13.37 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr2_+_90121477 | 13.26 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr22_-_27620603 | 13.08 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
chr1_-_153113927 | 13.04 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
chr19_+_50922187 | 12.96 |
ENST00000595883.1
ENST00000597855.1 ENST00000596074.1 ENST00000439922.2 ENST00000594685.1 ENST00000270632.7 |
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr18_-_74701962 | 12.92 |
ENST00000585201.1
|
MBP
|
myelin basic protein |
chr5_-_139944196 | 12.79 |
ENST00000357560.4
|
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr12_-_45307711 | 12.77 |
ENST00000333837.4
ENST00000551949.1 |
NELL2
|
NEL-like 2 (chicken) |
chr22_+_23247030 | 12.76 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr3_-_121379739 | 12.36 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr7_+_72742178 | 12.32 |
ENST00000442793.1
ENST00000413573.2 ENST00000252037.4 |
FKBP6
|
FK506 binding protein 6, 36kDa |
chrX_+_64708615 | 12.28 |
ENST00000338957.4
ENST00000423889.3 |
ZC3H12B
|
zinc finger CCCH-type containing 12B |
chr12_-_91573132 | 12.25 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
chr11_-_111781554 | 12.17 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr14_-_106322288 | 12.14 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr3_-_138763734 | 12.00 |
ENST00000413199.1
ENST00000502927.2 |
PRR23C
|
proline rich 23C |
chr6_-_32095968 | 11.97 |
ENST00000375203.3
ENST00000375201.4 |
ATF6B
|
activating transcription factor 6 beta |
chr19_-_36523709 | 11.93 |
ENST00000592017.1
ENST00000360535.4 |
CLIP3
|
CAP-GLY domain containing linker protein 3 |
chr11_+_124609742 | 11.93 |
ENST00000284292.6
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
chr8_-_27468842 | 11.92 |
ENST00000523500.1
|
CLU
|
clusterin |
chr22_+_29876197 | 11.89 |
ENST00000310624.6
|
NEFH
|
neurofilament, heavy polypeptide |
chr1_+_156123318 | 11.89 |
ENST00000368285.3
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr13_+_53226963 | 11.88 |
ENST00000343788.6
ENST00000535397.1 ENST00000310528.8 |
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
chr6_+_32407619 | 11.80 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr1_+_156589051 | 11.74 |
ENST00000255039.1
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2 |
chr1_+_171810606 | 11.73 |
ENST00000358155.4
ENST00000367733.2 ENST00000355305.5 ENST00000367731.1 |
DNM3
|
dynamin 3 |
chr4_-_46911223 | 11.63 |
ENST00000396533.1
|
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
chr4_+_128554081 | 11.57 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
chr6_-_31514333 | 11.57 |
ENST00000376151.4
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
chr11_+_124609823 | 11.55 |
ENST00000412681.2
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
chr19_-_50316489 | 11.50 |
ENST00000533418.1
|
FUZ
|
fuzzy planar cell polarity protein |
chr14_-_106406090 | 11.44 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr22_+_22681656 | 11.37 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr1_+_153330322 | 11.36 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr15_+_43803143 | 11.34 |
ENST00000382031.1
|
MAP1A
|
microtubule-associated protein 1A |
chrX_-_13835147 | 11.30 |
ENST00000493677.1
ENST00000355135.2 |
GPM6B
|
glycoprotein M6B |
chr12_-_15104040 | 11.27 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr11_-_117748138 | 11.26 |
ENST00000527717.1
|
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr22_+_23229960 | 11.16 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr4_-_46911248 | 11.13 |
ENST00000355591.3
ENST00000505102.1 |
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
chr7_+_100136811 | 11.13 |
ENST00000300176.4
ENST00000262935.4 |
AGFG2
|
ArfGAP with FG repeats 2 |
chr1_+_152635854 | 11.12 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
chr16_+_222846 | 11.03 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr17_-_29624343 | 11.02 |
ENST00000247271.4
|
OMG
|
oligodendrocyte myelin glycoprotein |
chr12_+_79258444 | 11.01 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
chr14_+_75746781 | 11.01 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr3_-_126194707 | 10.98 |
ENST00000336332.5
ENST00000389709.3 |
ZXDC
|
ZXD family zinc finger C |
chr6_+_31515337 | 10.97 |
ENST00000376148.4
ENST00000376145.4 |
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
chr11_-_64510409 | 10.97 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr19_+_41903709 | 10.87 |
ENST00000542943.1
ENST00000457836.2 |
BCKDHA
|
branched chain keto acid dehydrogenase E1, alpha polypeptide |
chrX_+_8433376 | 10.85 |
ENST00000440654.2
ENST00000381029.4 |
VCX3B
|
variable charge, X-linked 3B |
chr18_-_53069419 | 10.81 |
ENST00000570177.2
|
TCF4
|
transcription factor 4 |
chr11_-_111781610 | 10.76 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr18_-_47813940 | 10.75 |
ENST00000586837.1
ENST00000412036.2 ENST00000589940.1 |
CXXC1
|
CXXC finger protein 1 |
chr7_+_72742162 | 10.74 |
ENST00000431982.2
|
FKBP6
|
FK506 binding protein 6, 36kDa |
chr11_-_111782696 | 10.74 |
ENST00000227251.3
ENST00000526180.1 |
CRYAB
|
crystallin, alpha B |
chr9_-_130712995 | 10.70 |
ENST00000373084.4
|
FAM102A
|
family with sequence similarity 102, member A |
chrX_+_16737718 | 10.68 |
ENST00000380155.3
|
SYAP1
|
synapse associated protein 1 |
chr11_-_111794446 | 10.66 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
chr9_+_139874683 | 10.66 |
ENST00000444903.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr17_+_4843413 | 10.64 |
ENST00000572430.1
ENST00000262482.6 |
RNF167
|
ring finger protein 167 |
chr19_-_50316517 | 10.58 |
ENST00000313777.4
ENST00000445575.2 |
FUZ
|
fuzzy planar cell polarity protein |
chr3_-_15140629 | 10.58 |
ENST00000507357.1
ENST00000449050.1 ENST00000253699.3 ENST00000435849.3 ENST00000476527.2 |
ZFYVE20
|
zinc finger, FYVE domain containing 20 |
chr12_-_71182695 | 10.54 |
ENST00000342084.4
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
chr15_+_74422585 | 10.50 |
ENST00000561740.1
ENST00000435464.1 ENST00000453268.2 |
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2 |
chr12_-_11508520 | 10.43 |
ENST00000545626.1
ENST00000500254.2 |
PRB1
|
proline-rich protein BstNI subfamily 1 |
chr2_+_90060377 | 10.43 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr7_+_24323782 | 10.42 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
chr9_+_124088860 | 10.23 |
ENST00000373806.1
|
GSN
|
gelsolin |
chr19_+_40854559 | 10.22 |
ENST00000598962.1
ENST00000409419.1 ENST00000409587.1 ENST00000602131.1 ENST00000409735.4 ENST00000600948.1 ENST00000356508.5 ENST00000596682.1 ENST00000594908.1 |
PLD3
|
phospholipase D family, member 3 |
chr16_-_30032610 | 10.20 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
chr14_-_106092403 | 10.17 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chrX_+_103031421 | 10.11 |
ENST00000433491.1
ENST00000418604.1 ENST00000443502.1 |
PLP1
|
proteolipid protein 1 |
chr4_-_109684120 | 10.05 |
ENST00000512646.1
ENST00000411864.2 ENST00000296486.3 ENST00000510706.1 |
ETNPPL
|
ethanolamine-phosphate phospho-lyase |
chr3_-_16524357 | 10.00 |
ENST00000432519.1
|
RFTN1
|
raftlin, lipid raft linker 1 |
chr11_-_111782484 | 9.96 |
ENST00000533971.1
|
CRYAB
|
crystallin, alpha B |
chr19_-_18314836 | 9.95 |
ENST00000464076.3
ENST00000222256.4 |
RAB3A
|
RAB3A, member RAS oncogene family |
chr16_+_55542910 | 9.94 |
ENST00000262134.5
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2 |
chr19_+_58694396 | 9.93 |
ENST00000326804.4
ENST00000345813.3 ENST00000424679.2 |
ZNF274
|
zinc finger protein 274 |
chr14_-_106237742 | 9.91 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr17_+_33448593 | 9.90 |
ENST00000158009.5
|
FNDC8
|
fibronectin type III domain containing 8 |
chr14_+_29236269 | 9.89 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
chr2_+_131769256 | 9.85 |
ENST00000355771.3
|
ARHGEF4
|
Rho guanine nucleotide exchange factor (GEF) 4 |
chr12_+_93772402 | 9.78 |
ENST00000546925.1
|
NUDT4
|
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
chr11_+_118215036 | 9.73 |
ENST00000392883.2
ENST00000532917.1 |
CD3G
|
CD3g molecule, gamma (CD3-TCR complex) |
chr1_+_46972668 | 9.71 |
ENST00000371956.4
ENST00000360032.3 |
DMBX1
|
diencephalon/mesencephalon homeobox 1 |
chr12_-_11422739 | 9.71 |
ENST00000279573.7
|
PRB3
|
proline-rich protein BstNI subfamily 3 |
chr11_-_117747607 | 9.69 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr1_+_160097462 | 9.68 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr17_+_77681075 | 9.68 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
chr12_+_79258547 | 9.65 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr2_+_90077680 | 9.64 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr4_-_84406218 | 9.61 |
ENST00000515303.1
|
FAM175A
|
family with sequence similarity 175, member A |
chr9_-_115818951 | 9.58 |
ENST00000553380.1
ENST00000374227.3 |
ZFP37
|
ZFP37 zinc finger protein |
chr3_+_14989186 | 9.57 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
chr7_-_37488834 | 9.57 |
ENST00000310758.4
|
ELMO1
|
engulfment and cell motility 1 |
chr1_-_203151933 | 9.54 |
ENST00000404436.2
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39) |
chr5_+_156693159 | 9.51 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr22_+_23101182 | 9.51 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr19_+_16435625 | 9.50 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr17_-_26903900 | 9.43 |
ENST00000395319.3
ENST00000581807.1 ENST00000584086.1 ENST00000395321.2 |
ALDOC
|
aldolase C, fructose-bisphosphate |
chrX_-_57937067 | 9.41 |
ENST00000358697.4
|
ZXDA
|
zinc finger, X-linked, duplicated A |
chr3_+_10068095 | 9.39 |
ENST00000287647.3
ENST00000383807.1 ENST00000383806.1 ENST00000419585.1 |
FANCD2
|
Fanconi anemia, complementation group D2 |
chrX_-_6453159 | 9.39 |
ENST00000381089.3
ENST00000398729.1 |
VCX3A
|
variable charge, X-linked 3A |
chr19_-_55668093 | 9.38 |
ENST00000588882.1
ENST00000586858.1 |
TNNI3
|
troponin I type 3 (cardiac) |
chr1_+_151254738 | 9.25 |
ENST00000336715.6
ENST00000324048.5 ENST00000368879.2 |
ZNF687
|
zinc finger protein 687 |
chrX_+_55478538 | 9.23 |
ENST00000342972.1
|
MAGEH1
|
melanoma antigen family H, 1 |
chr6_+_7108210 | 9.23 |
ENST00000467782.1
ENST00000334984.6 ENST00000349384.6 |
RREB1
|
ras responsive element binding protein 1 |
chr19_-_37019136 | 9.22 |
ENST00000592282.1
|
ZNF260
|
zinc finger protein 260 |
chr11_+_1889880 | 9.20 |
ENST00000405957.2
|
LSP1
|
lymphocyte-specific protein 1 |
chrX_-_1572629 | 9.17 |
ENST00000534940.1
|
ASMTL
|
acetylserotonin O-methyltransferase-like |
chrY_-_16098393 | 9.16 |
ENST00000250825.4
|
VCY
|
variable charge, Y-linked |
chr6_-_62996066 | 9.15 |
ENST00000281156.4
|
KHDRBS2
|
KH domain containing, RNA binding, signal transduction associated 2 |
chr7_-_5553369 | 9.15 |
ENST00000453700.3
ENST00000382368.3 |
FBXL18
|
F-box and leucine-rich repeat protein 18 |
chr22_-_17680472 | 9.07 |
ENST00000330232.4
|
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr12_-_54121261 | 9.06 |
ENST00000549784.1
ENST00000262059.4 |
CALCOCO1
|
calcium binding and coiled-coil domain 1 |
chr19_-_13617037 | 9.05 |
ENST00000360228.5
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr14_-_21516590 | 9.03 |
ENST00000555026.1
|
NDRG2
|
NDRG family member 2 |
chr6_-_33048483 | 9.02 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr6_+_31554636 | 9.00 |
ENST00000433492.1
|
LST1
|
leukocyte specific transcript 1 |
chr9_-_93405352 | 8.99 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr19_+_57999079 | 8.99 |
ENST00000426954.2
ENST00000354197.4 ENST00000523882.1 ENST00000520540.1 ENST00000519310.1 ENST00000442920.2 ENST00000523312.1 ENST00000424930.2 |
ZNF419
|
zinc finger protein 419 |
chr6_-_84419101 | 8.97 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr22_+_23237555 | 8.96 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr1_+_92632542 | 8.87 |
ENST00000409154.4
ENST00000370378.4 |
KIAA1107
|
KIAA1107 |
chr10_-_99531709 | 8.87 |
ENST00000266066.3
|
SFRP5
|
secreted frizzled-related protein 5 |
chr1_+_156124162 | 8.87 |
ENST00000368282.1
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr19_-_50316423 | 8.84 |
ENST00000528094.1
ENST00000526575.1 |
FUZ
|
fuzzy planar cell polarity protein |
chr11_-_62477041 | 8.82 |
ENST00000433053.1
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
chr12_-_11463353 | 8.82 |
ENST00000279575.1
ENST00000535904.1 ENST00000445719.2 |
PRB4
|
proline-rich protein BstNI subfamily 4 |
chr2_-_89266286 | 8.74 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr2_-_85555086 | 8.71 |
ENST00000444342.2
ENST00000409232.3 ENST00000409015.1 |
TGOLN2
|
trans-golgi network protein 2 |
chr10_-_75226166 | 8.69 |
ENST00000544628.1
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme |
chr17_-_29641084 | 8.69 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr16_+_1756162 | 8.69 |
ENST00000250894.4
ENST00000356010.5 |
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3 |
chr2_-_136288113 | 8.66 |
ENST00000401392.1
|
ZRANB3
|
zinc finger, RAN-binding domain containing 3 |
chr19_-_51527467 | 8.65 |
ENST00000593681.1
|
KLK11
|
kallikrein-related peptidase 11 |
chr11_+_121447469 | 8.61 |
ENST00000532694.1
ENST00000534286.1 |
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr18_-_53303123 | 8.56 |
ENST00000569357.1
ENST00000565124.1 ENST00000398339.1 |
TCF4
|
transcription factor 4 |
chr19_+_15852203 | 8.51 |
ENST00000305892.1
|
OR10H3
|
olfactory receptor, family 10, subfamily H, member 3 |
chr5_-_139943830 | 8.50 |
ENST00000412920.3
ENST00000511201.2 ENST00000356738.2 ENST00000354402.5 ENST00000358580.5 ENST00000508496.2 |
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr14_-_21493123 | 8.50 |
ENST00000556147.1
ENST00000554489.1 ENST00000555657.1 ENST00000557274.1 ENST00000555158.1 ENST00000554833.1 ENST00000555384.1 ENST00000556420.1 ENST00000554893.1 ENST00000553503.1 ENST00000555733.1 ENST00000553867.1 ENST00000397856.3 ENST00000397855.3 ENST00000556008.1 ENST00000557182.1 ENST00000554483.1 ENST00000556688.1 ENST00000397853.3 ENST00000556329.2 ENST00000554143.1 ENST00000397851.2 ENST00000555142.1 ENST00000557676.1 ENST00000556924.1 |
NDRG2
|
NDRG family member 2 |
chr2_-_51259292 | 8.48 |
ENST00000401669.2
|
NRXN1
|
neurexin 1 |
chr20_-_48532019 | 8.46 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
chr16_+_58283814 | 8.41 |
ENST00000443128.2
ENST00000219299.4 |
CCDC113
|
coiled-coil domain containing 113 |
chr19_+_18723660 | 8.39 |
ENST00000262817.3
|
TMEM59L
|
transmembrane protein 59-like |
chr2_-_51259229 | 8.38 |
ENST00000405472.3
|
NRXN1
|
neurexin 1 |
chr7_-_38671098 | 8.37 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
chr10_+_74451883 | 8.35 |
ENST00000373053.3
ENST00000357157.6 |
MCU
|
mitochondrial calcium uniporter |
chr3_-_49131473 | 8.32 |
ENST00000430979.1
ENST00000357496.2 ENST00000437939.1 |
QRICH1
|
glutamine-rich 1 |
chr8_+_24772455 | 8.32 |
ENST00000433454.2
|
NEFM
|
neurofilament, medium polypeptide |
chr2_+_17935383 | 8.32 |
ENST00000524465.1
ENST00000381254.2 ENST00000532257.1 |
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr14_-_50065882 | 8.28 |
ENST00000539688.1
|
AL139099.1
|
Full-length cDNA clone CS0DK012YO09 of HeLa cells of Homo sapiens (human); Uncharacterized protein |
chr5_-_39274617 | 8.23 |
ENST00000510188.1
|
FYB
|
FYN binding protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 34.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
9.3 | 27.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
7.7 | 30.9 | GO:0090299 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
7.5 | 22.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
7.2 | 43.1 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
6.7 | 20.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
6.7 | 20.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
6.5 | 26.0 | GO:0030185 | nitric oxide transport(GO:0030185) |
6.0 | 18.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
5.5 | 16.6 | GO:1905246 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
5.5 | 21.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
5.1 | 25.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
4.8 | 38.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
4.4 | 21.9 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
4.4 | 17.5 | GO:0019046 | release from viral latency(GO:0019046) |
4.2 | 12.7 | GO:1904395 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
4.2 | 4.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
4.1 | 4.1 | GO:2000785 | regulation of vacuole organization(GO:0044088) regulation of autophagosome assembly(GO:2000785) |
4.1 | 16.2 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
4.0 | 15.9 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
3.9 | 11.7 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
3.8 | 3.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
3.8 | 15.4 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
3.8 | 38.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.8 | 11.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
3.8 | 11.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
3.7 | 531.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
3.7 | 3.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
3.7 | 11.1 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
3.6 | 3.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
3.5 | 28.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
3.4 | 40.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
3.4 | 6.8 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
3.4 | 10.1 | GO:2000547 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
3.3 | 10.0 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
3.2 | 13.0 | GO:0036343 | psychomotor behavior(GO:0036343) |
3.2 | 9.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
3.2 | 6.4 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
3.2 | 12.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
3.2 | 3.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
3.2 | 12.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
3.2 | 6.3 | GO:0046823 | negative regulation of nucleocytoplasmic transport(GO:0046823) negative regulation of cytoplasmic transport(GO:1903650) |
3.1 | 3.1 | GO:0009798 | axis specification(GO:0009798) |
3.1 | 12.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
3.1 | 52.3 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
3.0 | 6.0 | GO:0007412 | axon target recognition(GO:0007412) |
3.0 | 53.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
2.9 | 17.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
2.9 | 8.7 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
2.8 | 8.5 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
2.8 | 8.5 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
2.8 | 22.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.8 | 8.3 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
2.7 | 2.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
2.7 | 5.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
2.7 | 8.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
2.6 | 18.5 | GO:0045007 | depurination(GO:0045007) |
2.6 | 10.4 | GO:0015819 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
2.6 | 12.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
2.5 | 10.1 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
2.5 | 5.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.5 | 7.5 | GO:0021586 | pons maturation(GO:0021586) |
2.5 | 5.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
2.5 | 24.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
2.5 | 9.9 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
2.4 | 4.9 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
2.4 | 7.3 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
2.4 | 2.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
2.4 | 2.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
2.4 | 11.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
2.3 | 11.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
2.3 | 9.3 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
2.3 | 9.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
2.3 | 2.3 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
2.3 | 4.5 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
2.2 | 9.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
2.2 | 4.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
2.2 | 8.9 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
2.2 | 11.0 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
2.2 | 12.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
2.1 | 17.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
2.1 | 14.9 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
2.1 | 8.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.1 | 6.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.1 | 6.4 | GO:1904640 | response to methionine(GO:1904640) |
2.1 | 4.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
2.1 | 6.3 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
2.1 | 21.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
2.1 | 6.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
2.1 | 10.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
2.1 | 6.2 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
2.1 | 8.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.0 | 6.1 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
2.0 | 10.2 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
2.0 | 8.2 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
2.0 | 6.1 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
2.0 | 8.1 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
2.0 | 4.0 | GO:0021558 | trochlear nerve development(GO:0021558) |
2.0 | 12.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
2.0 | 31.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
2.0 | 5.9 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
2.0 | 7.9 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
2.0 | 7.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
2.0 | 13.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
2.0 | 21.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
2.0 | 39.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.9 | 13.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.9 | 34.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.9 | 7.6 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
1.9 | 5.7 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
1.9 | 5.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.9 | 9.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
1.9 | 22.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.9 | 3.7 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
1.8 | 9.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.8 | 3.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.8 | 10.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.8 | 5.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.8 | 7.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.8 | 7.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.8 | 3.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.8 | 5.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
1.8 | 5.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.8 | 19.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.8 | 30.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.7 | 8.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.7 | 17.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.7 | 19.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.7 | 8.7 | GO:0048478 | replication fork protection(GO:0048478) |
1.7 | 6.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
1.7 | 1.7 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) |
1.7 | 5.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
1.7 | 5.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.7 | 3.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.7 | 8.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.7 | 5.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.7 | 5.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.7 | 18.6 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.7 | 5.1 | GO:0007538 | primary sex determination(GO:0007538) |
1.7 | 27.0 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
1.7 | 1.7 | GO:0042461 | photoreceptor cell development(GO:0042461) |
1.7 | 10.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.7 | 6.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.7 | 5.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.7 | 1.7 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
1.7 | 10.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.6 | 4.9 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
1.6 | 4.9 | GO:0035441 | cardiac left ventricle formation(GO:0003218) cell migration involved in vasculogenesis(GO:0035441) |
1.6 | 1.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.6 | 6.4 | GO:0042335 | cuticle development(GO:0042335) |
1.6 | 4.8 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
1.6 | 6.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.6 | 6.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.6 | 1.6 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
1.6 | 9.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.6 | 19.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.6 | 40.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.6 | 4.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.6 | 12.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.6 | 3.1 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
1.5 | 4.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.5 | 1.5 | GO:0030317 | sperm motility(GO:0030317) |
1.5 | 6.1 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
1.5 | 7.6 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
1.5 | 6.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.5 | 3.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
1.5 | 4.5 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
1.5 | 1.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.5 | 4.4 | GO:0031627 | telomeric loop formation(GO:0031627) |
1.5 | 4.4 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
1.4 | 2.9 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
1.4 | 21.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.4 | 1.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.4 | 5.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.4 | 7.2 | GO:0080009 | mRNA methylation(GO:0080009) |
1.4 | 1.4 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.4 | 2.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
1.4 | 8.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.4 | 2.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.4 | 7.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.4 | 5.6 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
1.4 | 7.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
1.4 | 25.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.4 | 9.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.4 | 4.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.4 | 4.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.4 | 5.5 | GO:0021633 | optic nerve structural organization(GO:0021633) |
1.4 | 4.1 | GO:0046066 | dGDP metabolic process(GO:0046066) |
1.4 | 4.1 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
1.4 | 5.5 | GO:1900228 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
1.4 | 4.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.4 | 6.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.4 | 4.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
1.4 | 6.8 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
1.3 | 5.4 | GO:1900168 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
1.3 | 16.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.3 | 4.0 | GO:1903487 | regulation of lactation(GO:1903487) |
1.3 | 1.3 | GO:0060939 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
1.3 | 10.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.3 | 6.6 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
1.3 | 4.0 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
1.3 | 9.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
1.3 | 2.6 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
1.3 | 3.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.3 | 2.6 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
1.3 | 7.8 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
1.3 | 3.9 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
1.3 | 2.6 | GO:0008272 | sulfate transport(GO:0008272) |
1.3 | 18.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.3 | 6.5 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
1.3 | 22.0 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
1.3 | 1.3 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
1.3 | 6.4 | GO:0070842 | aggresome assembly(GO:0070842) |
1.3 | 7.6 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
1.3 | 2.5 | GO:0002215 | defense response to nematode(GO:0002215) |
1.3 | 37.8 | GO:0045730 | respiratory burst(GO:0045730) |
1.3 | 3.8 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
1.3 | 3.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.3 | 3.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.3 | 42.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
1.2 | 5.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
1.2 | 8.7 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.2 | 2.5 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
1.2 | 6.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.2 | 2.5 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
1.2 | 11.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
1.2 | 9.8 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.2 | 11.0 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
1.2 | 6.1 | GO:0030070 | insulin processing(GO:0030070) |
1.2 | 4.9 | GO:0006304 | DNA modification(GO:0006304) |
1.2 | 3.6 | GO:0051697 | protein delipidation(GO:0051697) |
1.2 | 6.0 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 4.8 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
1.2 | 18.0 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
1.2 | 3.6 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
1.2 | 3.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.2 | 4.8 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
1.2 | 7.2 | GO:0018343 | protein farnesylation(GO:0018343) |
1.2 | 3.6 | GO:1904647 | response to rotenone(GO:1904647) |
1.2 | 3.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
1.2 | 7.0 | GO:0015811 | L-cystine transport(GO:0015811) |
1.2 | 8.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
1.2 | 14.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
1.2 | 3.5 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
1.2 | 5.8 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
1.2 | 6.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.2 | 3.5 | GO:0043315 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) positive regulation of leukocyte tethering or rolling(GO:1903238) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.2 | 1.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
1.1 | 39.0 | GO:0008038 | neuron recognition(GO:0008038) |
1.1 | 9.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.1 | 5.7 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
1.1 | 11.3 | GO:0015889 | cobalamin transport(GO:0015889) |
1.1 | 2.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.1 | 13.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
1.1 | 5.6 | GO:1904383 | response to sodium phosphate(GO:1904383) |
1.1 | 2.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.1 | 5.5 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.1 | 3.3 | GO:1902019 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.1 | 3.3 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
1.1 | 5.5 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
1.1 | 3.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
1.1 | 11.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.1 | 6.5 | GO:0099612 | protein localization to axon(GO:0099612) |
1.1 | 21.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.1 | 3.2 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
1.1 | 2.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.1 | 9.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.1 | 3.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.1 | 3.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
1.1 | 3.2 | GO:1904800 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.1 | 12.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.1 | 6.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.1 | 5.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.1 | 5.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.0 | 3.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.0 | 1.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
1.0 | 2.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
1.0 | 6.2 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
1.0 | 3.1 | GO:2000078 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
1.0 | 2.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.0 | 5.1 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
1.0 | 3.1 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
1.0 | 2.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.0 | 8.2 | GO:0006531 | aspartate metabolic process(GO:0006531) |
1.0 | 12.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.0 | 34.6 | GO:0090383 | phagosome acidification(GO:0090383) |
1.0 | 8.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 1.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
1.0 | 5.1 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
1.0 | 3.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.0 | 1.0 | GO:1901374 | acetate ester transport(GO:1901374) |
1.0 | 3.0 | GO:0071529 | cementum mineralization(GO:0071529) |
1.0 | 6.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.0 | 3.0 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.0 | 3.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.0 | 8.0 | GO:0046689 | response to mercury ion(GO:0046689) |
1.0 | 21.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.0 | 3.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.0 | 6.9 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
1.0 | 10.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.0 | 5.9 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.0 | 5.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.0 | 5.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.0 | 2.0 | GO:0060326 | cell chemotaxis(GO:0060326) |
1.0 | 2.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.0 | 5.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
1.0 | 2.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.0 | 13.6 | GO:0015671 | oxygen transport(GO:0015671) |
1.0 | 3.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
1.0 | 2.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.0 | 4.8 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
1.0 | 2.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.0 | 19.3 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
1.0 | 6.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.0 | 6.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.0 | 1.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.0 | 7.6 | GO:0070166 | enamel mineralization(GO:0070166) |
1.0 | 10.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
1.0 | 15.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.0 | 2.9 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
1.0 | 6.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.0 | 1.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.9 | 4.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.9 | 14.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.9 | 3.8 | GO:0072658 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.9 | 5.7 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.9 | 1.9 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.9 | 12.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.9 | 3.7 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.9 | 2.8 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.9 | 8.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.9 | 4.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.9 | 2.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.9 | 5.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 6.4 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.9 | 6.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 2.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.9 | 13.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.9 | 4.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.9 | 4.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.9 | 1.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.9 | 4.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.9 | 2.7 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.9 | 7.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.9 | 2.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.9 | 7.0 | GO:0021794 | thalamus development(GO:0021794) |
0.9 | 3.5 | GO:0018210 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.9 | 2.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.9 | 4.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.9 | 5.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.9 | 2.6 | GO:1904936 | cerebral cortex tangential migration(GO:0021800) cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.9 | 3.5 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.9 | 9.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 2.6 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.9 | 5.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.9 | 3.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.8 | 0.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 1.7 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.8 | 1.7 | GO:1901658 | glycoside catabolic process(GO:0016139) glycosyl compound catabolic process(GO:1901658) |
0.8 | 1.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.8 | 13.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.8 | 5.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.8 | 4.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.8 | 2.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.8 | 3.3 | GO:0048749 | compound eye development(GO:0048749) |
0.8 | 2.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.8 | 4.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) |
0.8 | 4.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.8 | 2.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.8 | 1.6 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.8 | 4.0 | GO:0044336 | embryonic genitalia morphogenesis(GO:0030538) canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.8 | 11.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.8 | 6.5 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.8 | 2.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.8 | 3.2 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.8 | 8.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.8 | 1.6 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.8 | 2.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.8 | 2.4 | GO:0070213 | negative regulation of sister chromatid cohesion(GO:0045875) protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 4.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.8 | 4.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.8 | 4.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.8 | 5.5 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.8 | 1.6 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.8 | 6.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.8 | 3.9 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.8 | 2.3 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.8 | 5.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.8 | 1.6 | GO:0007320 | insemination(GO:0007320) |
0.8 | 10.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.8 | 24.8 | GO:0015695 | organic cation transport(GO:0015695) |
0.8 | 3.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.8 | 4.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.8 | 2.3 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.8 | 2.3 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.8 | 6.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.8 | 2.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 38.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.8 | 2.3 | GO:0032663 | regulation of interleukin-2 production(GO:0032663) |
0.8 | 1.5 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.8 | 1.5 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.8 | 0.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.8 | 6.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.8 | 3.8 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.7 | 30.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.7 | 2.2 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.7 | 2.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.7 | 2.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.7 | 1.5 | GO:0002384 | hepatic immune response(GO:0002384) |
0.7 | 3.0 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.7 | 0.7 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.7 | 13.3 | GO:0030220 | platelet formation(GO:0030220) |
0.7 | 2.9 | GO:0007614 | short-term memory(GO:0007614) |
0.7 | 0.7 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.7 | 5.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.7 | 2.9 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.7 | 8.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.7 | 0.7 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.7 | 1.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.7 | 7.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.7 | 2.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.7 | 6.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.7 | 13.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.7 | 1.4 | GO:0071864 | regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.7 | 62.4 | GO:0031294 | lymphocyte costimulation(GO:0031294) |
0.7 | 2.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.7 | 15.0 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.7 | 10.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.7 | 2.1 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.7 | 2.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.7 | 3.5 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.7 | 2.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.7 | 1.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.7 | 0.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.7 | 9.1 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.7 | 4.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.7 | 7.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 7.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.7 | 8.4 | GO:0098655 | cation transmembrane transport(GO:0098655) |
0.7 | 4.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.7 | 2.8 | GO:0033121 | regulation of cyclic nucleotide catabolic process(GO:0030805) positive regulation of cyclic nucleotide catabolic process(GO:0030807) regulation of cAMP catabolic process(GO:0030820) positive regulation of cAMP catabolic process(GO:0030822) regulation of purine nucleotide catabolic process(GO:0033121) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.7 | 2.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.7 | 2.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.7 | 7.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.7 | 2.0 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.7 | 2.0 | GO:0034699 | response to luteinizing hormone(GO:0034699) cellular response to luteinizing hormone stimulus(GO:0071373) |
0.7 | 3.4 | GO:1903278 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.7 | 1.4 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.7 | 5.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.7 | 1.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.7 | 3.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.7 | 2.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
0.7 | 2.6 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.7 | 3.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.7 | 4.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.7 | 12.5 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.7 | 1.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.7 | 2.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.7 | 25.6 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.7 | 6.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.7 | 3.9 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.7 | 2.0 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.7 | 5.2 | GO:0019563 | glycerol catabolic process(GO:0019563) |
0.7 | 1.3 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.6 | 18.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 0.6 | GO:0042116 | macrophage activation(GO:0042116) |
0.6 | 2.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.6 | 1.9 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.6 | 9.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.6 | 6.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.6 | 5.1 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 2.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.6 | 1.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.6 | 6.3 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.6 | 8.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.6 | 1.9 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.6 | 15.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.6 | 16.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.6 | 3.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.6 | 1.2 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.6 | 0.6 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.6 | 1.2 | GO:0051785 | positive regulation of mitotic nuclear division(GO:0045840) positive regulation of nuclear division(GO:0051785) |
0.6 | 1.9 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.6 | 5.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 4.3 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.6 | 0.6 | GO:0010171 | body morphogenesis(GO:0010171) |
0.6 | 1.2 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.6 | 1.8 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.6 | 6.8 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.6 | 1.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.6 | 2.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.6 | 6.7 | GO:0045008 | depyrimidination(GO:0045008) |
0.6 | 1.2 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.6 | 4.3 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.6 | 1.8 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.6 | 5.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 5.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.6 | 2.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.6 | 8.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.6 | 1.8 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.6 | 2.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.6 | 1.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 1.8 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.6 | 3.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 2.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.6 | 2.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 4.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.6 | 1.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.6 | 6.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.6 | 1.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.6 | 1.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.6 | 0.6 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.6 | 2.9 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.6 | 1.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.6 | 25.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.6 | 1.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 1.7 | GO:0034201 | response to oleic acid(GO:0034201) |
0.6 | 1.7 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 3.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 1.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.6 | 73.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.6 | 5.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.6 | 5.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.6 | 0.6 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.6 | 1.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.5 | 3.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 0.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.5 | 21.8 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.5 | 4.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 2.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.5 | 2.2 | GO:2001206 | positive regulation of bone development(GO:1903012) positive regulation of osteoclast development(GO:2001206) |
0.5 | 6.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 2.2 | GO:0003335 | corneocyte development(GO:0003335) |
0.5 | 3.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 3.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.5 | 1.1 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.5 | 1.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.5 | 9.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.5 | 2.7 | GO:0097338 | response to clozapine(GO:0097338) |
0.5 | 20.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.5 | 2.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 2.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.5 | 4.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 3.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.5 | 3.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.5 | 1.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.5 | 8.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.5 | 3.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.5 | 4.7 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.5 | 0.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.5 | 5.8 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 cell lineage commitment(GO:0072540) |
0.5 | 1.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.5 | 1.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.5 | 2.6 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.5 | 2.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.5 | 9.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.5 | 1.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.5 | 19.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.5 | 1.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.5 | 2.5 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.5 | 14.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.5 | 1.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 3.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.5 | 2.0 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.5 | 2.0 | GO:0036269 | swimming behavior(GO:0036269) |
0.5 | 0.5 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.5 | 1.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.5 | 1.5 | GO:0061056 | somite specification(GO:0001757) sclerotome development(GO:0061056) |
0.5 | 1.0 | GO:0015824 | proline transport(GO:0015824) |
0.5 | 2.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.5 | 5.9 | GO:0008016 | regulation of heart contraction(GO:0008016) |
0.5 | 1.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.5 | 1.5 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.5 | 1.5 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.5 | 2.4 | GO:0099624 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.5 | 1.9 | GO:0007548 | sex differentiation(GO:0007548) |
0.5 | 2.4 | GO:0001554 | luteolysis(GO:0001554) |
0.5 | 1.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.5 | 1.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 2.9 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.5 | 3.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 5.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.5 | 1.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.5 | 8.6 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.5 | 0.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 1.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.5 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 8.9 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.5 | 9.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 6.5 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.5 | 2.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 5.5 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.5 | 7.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.5 | 1.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.5 | 0.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.5 | 2.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.4 | 2.2 | GO:1902856 | microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.4 | 1.8 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.4 | 9.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.4 | 13.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 1.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.4 | 6.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.4 | 1.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.4 | 1.3 | GO:2000650 | negative regulation of sodium ion transport(GO:0010766) negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.4 | 1.3 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.4 | 1.3 | GO:2000683 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) regulation of cellular response to X-ray(GO:2000683) positive regulation of cellular response to X-ray(GO:2000685) |
0.4 | 3.9 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.4 | 1.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 12.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 4.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.4 | 2.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 0.9 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.4 | 4.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 8.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.4 | 18.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.4 | 12.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.4 | 1.3 | GO:0003431 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
0.4 | 2.1 | GO:0002415 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.4 | 2.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 1.3 | GO:0006573 | valine metabolic process(GO:0006573) |
0.4 | 2.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 0.8 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.4 | 2.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 0.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 1.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 0.8 | GO:0070633 | transepithelial transport(GO:0070633) |
0.4 | 2.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 2.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.4 | 0.8 | GO:0042220 | response to cocaine(GO:0042220) |
0.4 | 7.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.4 | 2.1 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.4 | 1.7 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.4 | 2.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 1.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.4 | 3.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.4 | 16.9 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.4 | 8.0 | GO:0098743 | cell aggregation(GO:0098743) |
0.4 | 5.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.4 | 3.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 4.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 0.8 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.4 | 5.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.4 | 0.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 5.0 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.4 | 4.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.4 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 3.9 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.4 | 4.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 7.3 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 4.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.4 | 1.1 | GO:0060214 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.4 | 4.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.4 | 2.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.4 | 3.0 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 2.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 0.7 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.4 | 1.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.4 | 2.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 2.6 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.4 | 2.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 2.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 2.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 1.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 1.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 2.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 1.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.4 | 3.6 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.4 | 3.6 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.4 | 1.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.4 | 2.8 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.4 | 0.7 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.4 | 48.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 0.3 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.3 | 4.9 | GO:0003341 | cilium movement(GO:0003341) |
0.3 | 7.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 1.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 18.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.4 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
0.3 | 2.1 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.3 | 1.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.3 | 3.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 3.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.3 | 2.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 1.4 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.3 | 1.7 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.3 | 1.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 2.0 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 3.0 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 2.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.3 | 3.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 1.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.3 | 4.2 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.3 | 4.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 6.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 2.6 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.3 | 1.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.3 | 1.9 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.3 | 1.6 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.3 | 0.6 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 2.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 1.6 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.3 | 3.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.3 | 1.6 | GO:0097178 | ruffle assembly(GO:0097178) |
0.3 | 0.9 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 1.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 0.9 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.3 | 2.8 | GO:0001756 | somitogenesis(GO:0001756) |
0.3 | 1.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.3 | 0.9 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.3 | 2.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 3.0 | GO:0071902 | positive regulation of protein serine/threonine kinase activity(GO:0071902) |
0.3 | 0.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 2.4 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.3 | 0.9 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.3 | 3.0 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 | 4.5 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.3 | 0.9 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.3 | 5.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.3 | 2.1 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.3 | 2.9 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.3 | 2.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.3 | 1.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 5.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 1.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.3 | 7.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 0.3 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
0.3 | 0.3 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 6.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 2.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 4.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 1.4 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.3 | 2.3 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.3 | 3.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 1.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 1.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.3 | 4.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 3.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 2.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 3.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.3 | 1.3 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.3 | 1.3 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.3 | 2.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 0.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 1.1 | GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.3 | 1.6 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.3 | 4.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 1.6 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.3 | 0.5 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 1.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.3 | 1.0 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.3 | 0.8 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.3 | 3.4 | GO:0014075 | response to amine(GO:0014075) |
0.3 | 3.6 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 3.6 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.3 | 2.3 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.3 | 4.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.3 | 2.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 2.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.3 | 1.5 | GO:0036065 | fucosylation(GO:0036065) protein O-linked fucosylation(GO:0036066) |
0.3 | 1.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 3.8 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.3 | 2.8 | GO:0007127 | meiosis I(GO:0007127) |
0.2 | 1.0 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 1.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 1.0 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.2 | 5.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 2.0 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 5.9 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.2 | 5.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 2.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 1.0 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.2 | 2.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 2.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 1.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 6.0 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.2 | 8.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 2.6 | GO:0001764 | neuron migration(GO:0001764) |
0.2 | 2.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 0.9 | GO:0002312 | B cell activation involved in immune response(GO:0002312) |
0.2 | 0.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.2 | 1.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 3.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.5 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 1.3 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.7 | GO:0042435 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
0.2 | 3.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.2 | 1.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.4 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 0.9 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 1.5 | GO:0006833 | water transport(GO:0006833) |
0.2 | 2.2 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.2 | 2.6 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.2 | 0.6 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.2 | 2.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 1.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 2.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.2 | GO:0044266 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.2 | 1.0 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 1.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.8 | GO:0007350 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 0.4 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 4.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.2 | 1.0 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.2 | 1.4 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 1.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 1.0 | GO:0035878 | nail development(GO:0035878) |
0.2 | 8.1 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.2 | 3.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 0.2 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 0.8 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 1.4 | GO:1904892 | regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
0.2 | 2.7 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 1.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 2.5 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.2 | 0.2 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.2 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 5.0 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.2 | 1.1 | GO:0090313 | regulation of protein targeting to membrane(GO:0090313) |
0.2 | 4.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 1.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 1.5 | GO:0048562 | embryonic organ morphogenesis(GO:0048562) |
0.2 | 1.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 0.4 | GO:0038001 | paracrine signaling(GO:0038001) |
0.2 | 2.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 13.9 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 1.8 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 4.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 1.1 | GO:0014744 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of muscle adaptation(GO:0014744) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.2 | 1.4 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.2 | 1.7 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.7 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.2 | 0.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 0.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) regulation of lymphangiogenesis(GO:1901490) |
0.2 | 0.5 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.2 | 0.7 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.2 | 1.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 1.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 1.3 | GO:0015886 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
0.2 | 0.5 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.2 | 2.8 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.2 | 0.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.2 | GO:0050880 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
0.2 | 1.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 1.0 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 1.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.2 | 5.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 1.4 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.2 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.3 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.2 | 1.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 7.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 1.8 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.2 | 3.5 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 0.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 0.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.9 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.7 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.9 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 1.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 1.9 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 1.4 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 5.4 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 1.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 1.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 2.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 1.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.1 | 1.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 1.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 2.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 1.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.5 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 5.0 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 2.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 4.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 1.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 2.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 1.6 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 0.8 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.1 | 6.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.1 | 1.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 1.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 1.0 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.1 | 0.7 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.6 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 6.9 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 1.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 1.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.8 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 4.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.7 | GO:0061008 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
0.1 | 0.7 | GO:0019374 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.1 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.3 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.1 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.4 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 2.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 1.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 1.5 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.1 | 1.9 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 1.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.4 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 0.8 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.1 | 0.2 | GO:0003174 | mitral valve development(GO:0003174) |
0.1 | 0.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 1.0 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.7 | GO:0035690 | cellular response to drug(GO:0035690) |
0.1 | 0.2 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 5.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.2 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.1 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.6 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 1.4 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 1.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 5.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 1.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.4 | GO:0061337 | cardiac conduction(GO:0061337) |
0.1 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 1.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.6 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 1.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.4 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.4 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.0 | 0.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.4 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.2 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 1.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.2 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.2 | GO:0090656 | t-circle formation(GO:0090656) |
0.0 | 0.2 | GO:0043506 | regulation of JUN kinase activity(GO:0043506) |
0.0 | 0.1 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.0 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.0 | 0.1 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.2 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.1 | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus(GO:0002562) somatic cell DNA recombination(GO:0016444) V(D)J recombination(GO:0033151) |
0.0 | 0.0 | GO:0097646 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 0.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.0 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.2 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.4 | 66.8 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
5.3 | 21.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.4 | 70.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
4.3 | 217.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
4.3 | 21.4 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
4.1 | 65.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
4.1 | 8.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
3.8 | 80.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
3.8 | 11.5 | GO:0019034 | viral replication complex(GO:0019034) |
3.6 | 17.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
3.3 | 36.2 | GO:0044327 | dendritic spine head(GO:0044327) |
3.2 | 9.6 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
3.1 | 15.6 | GO:0071546 | pi-body(GO:0071546) |
3.1 | 9.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
3.1 | 9.2 | GO:0030658 | transport vesicle membrane(GO:0030658) |
2.9 | 40.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
2.4 | 26.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.3 | 2.3 | GO:0008091 | spectrin(GO:0008091) |
2.3 | 13.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.3 | 4.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.3 | 29.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
2.2 | 6.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
2.2 | 17.5 | GO:0035976 | AP1 complex(GO:0035976) |
2.2 | 6.5 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
2.1 | 2.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
2.1 | 6.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
2.0 | 2.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
2.0 | 13.9 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
2.0 | 27.4 | GO:0033270 | paranode region of axon(GO:0033270) |
2.0 | 13.7 | GO:0019814 | immunoglobulin complex(GO:0019814) |
1.9 | 15.5 | GO:0033010 | paranodal junction(GO:0033010) |
1.9 | 7.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.8 | 12.9 | GO:0033269 | internode region of axon(GO:0033269) |
1.8 | 21.9 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
1.8 | 7.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
1.8 | 7.2 | GO:0014802 | terminal cisterna(GO:0014802) |
1.7 | 5.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.7 | 1.7 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.7 | 23.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
1.6 | 4.9 | GO:0060187 | cell pole(GO:0060187) |
1.6 | 8.0 | GO:0000801 | central element(GO:0000801) |
1.5 | 7.7 | GO:0036398 | TCR signalosome(GO:0036398) |
1.5 | 10.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.5 | 36.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
1.5 | 20.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.5 | 4.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.5 | 5.8 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
1.5 | 17.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.4 | 15.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.4 | 22.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.4 | 11.0 | GO:0097449 | astrocyte projection(GO:0097449) |
1.3 | 6.7 | GO:0001652 | granular component(GO:0001652) |
1.3 | 4.0 | GO:0044609 | DBIRD complex(GO:0044609) |
1.3 | 2.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.3 | 3.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
1.2 | 7.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.2 | 14.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.2 | 9.9 | GO:0043679 | axon terminus(GO:0043679) |
1.2 | 13.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.2 | 49.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.2 | 2.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.2 | 9.8 | GO:0032010 | phagolysosome(GO:0032010) |
1.2 | 2.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.2 | 11.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 6.8 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.1 | 3.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
1.1 | 3.3 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
1.1 | 3.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
1.1 | 37.6 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.1 | 4.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.1 | 6.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.0 | 5.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.0 | 4.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.0 | 1.0 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
1.0 | 2.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.0 | 3.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 3.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.0 | 5.0 | GO:0089701 | U2AF(GO:0089701) |
1.0 | 25.9 | GO:0034451 | centriolar satellite(GO:0034451) |
1.0 | 4.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.0 | 20.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.0 | 8.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.9 | 6.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.9 | 0.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.9 | 5.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.9 | 3.7 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.9 | 7.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.9 | 14.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.9 | 13.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 15.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.9 | 7.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.9 | 2.6 | GO:0016938 | kinesin I complex(GO:0016938) |
0.8 | 2.5 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 7.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.8 | 55.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.8 | 12.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 9.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.8 | 3.3 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.8 | 2.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 9.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.8 | 7.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.8 | 8.9 | GO:0012506 | vesicle membrane(GO:0012506) |
0.8 | 3.2 | GO:1990031 | pinceau fiber(GO:1990031) |
0.8 | 5.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.8 | 0.8 | GO:0042611 | MHC protein complex(GO:0042611) |
0.8 | 5.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.8 | 5.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 40.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 0.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 12.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 3.7 | GO:0032280 | symmetric synapse(GO:0032280) neuron to neuron synapse(GO:0098984) |
0.7 | 2.9 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.7 | 5.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.7 | 2.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.7 | 19.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.7 | 3.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.7 | 6.3 | GO:0030133 | transport vesicle(GO:0030133) |
0.7 | 1.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.7 | 4.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.7 | 8.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.7 | 5.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.6 | 2.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.6 | 6.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 6.9 | GO:0097433 | dense body(GO:0097433) |
0.6 | 97.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.6 | 10.5 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.6 | 2.4 | GO:1990745 | EARP complex(GO:1990745) |
0.6 | 7.2 | GO:0032420 | stereocilium(GO:0032420) |
0.6 | 11.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 8.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.6 | 1.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.6 | 30.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.6 | 3.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 2.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 3.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 4.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.5 | 8.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.5 | 2.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 28.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 48.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.5 | 3.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 4.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 2.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.5 | 2.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.5 | 1.5 | GO:0044447 | axoneme part(GO:0044447) |
0.5 | 2.0 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.5 | 44.8 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.5 | 5.5 | GO:0042599 | lamellar body(GO:0042599) |
0.5 | 2.9 | GO:1990037 | Lewy body core(GO:1990037) |
0.5 | 14.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 2.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.5 | 4.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 3.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 2.3 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 3.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 8.5 | GO:0031430 | M band(GO:0031430) |
0.4 | 1.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.4 | 104.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 2.6 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.4 | 6.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 6.0 | GO:0097227 | sperm annulus(GO:0097227) |
0.4 | 1.3 | GO:0060198 | clathrin-sculpted vesicle(GO:0060198) |
0.4 | 15.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.4 | 1.3 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 0.8 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.4 | 2.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 2.5 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 7.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.4 | 2.9 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.4 | 5.3 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 2.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.4 | 1.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 2.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 8.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 9.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 2.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 4.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 27.6 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 2.0 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 12.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 4.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 2.9 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 4.7 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.3 | 1.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 9.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 12.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 5.5 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 10.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 1.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.3 | 5.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 3.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 8.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 3.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 1.2 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.3 | 8.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 2.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 5.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 6.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 54.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 37.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 10.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 2.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 1.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 11.9 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 4.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 2.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.4 | GO:0002177 | manchette(GO:0002177) |
0.2 | 10.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 14.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 1.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 11.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 22.9 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 25.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 1.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 2.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 10.1 | GO:0005901 | caveola(GO:0005901) |
0.2 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.2 | 1.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 2.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 1.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 5.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 0.5 | GO:0033150 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
0.2 | 18.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 3.2 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 6.4 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 1.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 7.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 5.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 210.2 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 6.6 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 25.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 3.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 2.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 4.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 1.5 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 1.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 2.9 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 2.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.4 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 3.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 6.2 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 1.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 9.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 5.2 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 6.8 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 231.8 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.1 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 1.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 6.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 34.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
11.3 | 45.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
5.4 | 16.1 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
5.1 | 15.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
5.0 | 20.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
4.4 | 26.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
4.3 | 56.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
4.3 | 59.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
4.0 | 16.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
4.0 | 217.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
3.9 | 23.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
3.8 | 11.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
3.7 | 11.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
3.5 | 24.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
3.4 | 13.7 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
3.4 | 10.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
3.4 | 10.2 | GO:0034584 | piRNA binding(GO:0034584) |
3.4 | 47.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
3.2 | 12.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
3.2 | 12.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.2 | 9.5 | GO:0032093 | SAM domain binding(GO:0032093) |
3.1 | 12.3 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
3.0 | 8.9 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
3.0 | 14.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
2.9 | 8.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.9 | 8.7 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
2.8 | 8.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
2.8 | 13.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
2.8 | 33.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.7 | 10.7 | GO:0097001 | ceramide binding(GO:0097001) |
2.6 | 2.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.6 | 48.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
2.6 | 2.6 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
2.5 | 28.0 | GO:0008430 | selenium binding(GO:0008430) |
2.5 | 7.6 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
2.5 | 7.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
2.5 | 24.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.5 | 7.4 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
2.5 | 39.3 | GO:0038191 | neuropilin binding(GO:0038191) |
2.4 | 7.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
2.4 | 7.1 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
2.3 | 410.7 | GO:0003823 | antigen binding(GO:0003823) |
2.2 | 44.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
2.2 | 2.2 | GO:0043199 | sulfate binding(GO:0043199) |
2.2 | 13.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
2.1 | 6.4 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
2.1 | 2.1 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
2.1 | 29.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.1 | 6.4 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
2.1 | 12.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
2.1 | 2.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
2.1 | 8.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
2.0 | 10.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
2.0 | 10.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
2.0 | 2.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.0 | 11.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.9 | 3.9 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
1.9 | 9.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
1.9 | 7.6 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
1.9 | 5.7 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
1.9 | 13.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.9 | 57.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
1.9 | 7.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
1.8 | 5.5 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
1.8 | 3.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.8 | 7.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.8 | 5.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
1.8 | 9.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.7 | 5.2 | GO:0004769 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) steroid delta-isomerase activity(GO:0004769) |
1.7 | 5.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.7 | 10.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.7 | 5.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.7 | 13.6 | GO:0030172 | troponin C binding(GO:0030172) |
1.7 | 18.6 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
1.7 | 6.8 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.7 | 43.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.6 | 4.9 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.6 | 22.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.6 | 6.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
1.6 | 4.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.6 | 4.8 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
1.6 | 4.7 | GO:0005549 | odorant binding(GO:0005549) |
1.6 | 1.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.6 | 6.3 | GO:0030305 | heparanase activity(GO:0030305) |
1.5 | 4.6 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
1.5 | 4.6 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
1.5 | 7.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
1.5 | 6.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.5 | 4.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
1.5 | 3.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.5 | 4.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.5 | 5.8 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
1.4 | 5.7 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
1.4 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
1.4 | 4.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.4 | 7.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.4 | 5.5 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
1.4 | 21.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.4 | 12.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
1.4 | 9.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.4 | 8.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.3 | 7.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.3 | 3.9 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.3 | 6.5 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
1.3 | 2.6 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
1.3 | 3.8 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
1.3 | 6.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.3 | 21.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.3 | 3.8 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
1.3 | 16.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.2 | 3.7 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
1.2 | 13.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.2 | 4.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
1.2 | 17.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.2 | 6.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
1.2 | 24.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.2 | 14.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 14.5 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.2 | 4.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.2 | 4.8 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
1.2 | 3.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.2 | 11.9 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.2 | 3.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.2 | 14.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.2 | 4.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.2 | 3.5 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
1.1 | 29.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.1 | 5.7 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
1.1 | 2.3 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
1.1 | 3.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.1 | 4.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
1.1 | 29.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.1 | 6.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.1 | 3.4 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
1.1 | 4.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
1.1 | 6.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
1.1 | 14.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.1 | 4.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
1.1 | 2.2 | GO:0002046 | opsin binding(GO:0002046) |
1.1 | 6.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.1 | 3.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
1.1 | 3.2 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
1.1 | 4.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.1 | 3.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.1 | 8.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.1 | 14.8 | GO:0033691 | sialic acid binding(GO:0033691) |
1.1 | 3.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.0 | 5.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
1.0 | 3.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.0 | 3.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
1.0 | 11.3 | GO:0048156 | tau protein binding(GO:0048156) |
1.0 | 7.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.0 | 5.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.0 | 23.3 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.0 | 1.0 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
1.0 | 5.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.0 | 2.0 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
1.0 | 5.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.0 | 5.0 | GO:0004771 | sterol esterase activity(GO:0004771) methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
1.0 | 2.9 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.0 | 6.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
1.0 | 13.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.0 | 4.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.0 | 26.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.0 | 17.4 | GO:0099589 | serotonin receptor activity(GO:0099589) |
1.0 | 4.8 | GO:0052846 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
1.0 | 15.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 2.9 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.0 | 4.8 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.9 | 2.8 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.9 | 5.7 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.9 | 2.8 | GO:0017129 | triglyceride binding(GO:0017129) |
0.9 | 6.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 2.8 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.9 | 11.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.9 | 1.9 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.9 | 4.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.9 | 22.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.9 | 11.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.9 | 7.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.9 | 2.7 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.9 | 9.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.9 | 7.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 2.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.9 | 3.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.9 | 4.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.9 | 13.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.9 | 7.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.9 | 2.6 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.9 | 6.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.9 | 11.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.9 | 2.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.9 | 8.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 4.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.9 | 16.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.8 | 3.4 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.8 | 0.8 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.8 | 1.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.8 | 22.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.8 | 1.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.8 | 5.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.8 | 5.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.8 | 4.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.8 | 2.5 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.8 | 5.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.8 | 15.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.8 | 4.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.8 | 15.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.8 | 14.4 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 2.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.8 | 2.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.8 | 3.2 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.8 | 2.4 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.8 | 5.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.8 | 7.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 2.3 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.8 | 11.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.8 | 2.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.8 | 3.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.8 | 2.3 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.8 | 0.8 | GO:0019863 | IgE binding(GO:0019863) |
0.8 | 6.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.7 | 3.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.7 | 2.2 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.7 | 1.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.7 | 4.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 6.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 7.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.7 | 6.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 5.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.7 | 4.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.7 | 6.6 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.7 | 8.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.7 | 8.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.7 | 2.2 | GO:0017057 | glucose-6-phosphate dehydrogenase activity(GO:0004345) 6-phosphogluconolactonase activity(GO:0017057) |
0.7 | 7.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 10.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.7 | 2.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.7 | 2.1 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.7 | 21.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.7 | 2.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.7 | 2.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.7 | 4.9 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.7 | 3.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.7 | 6.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.7 | 2.8 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.7 | 2.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.7 | 2.7 | GO:0004803 | transposase activity(GO:0004803) |
0.7 | 3.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.7 | 2.7 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.7 | 21.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.7 | 2.0 | GO:0015333 | oligopeptide transporter activity(GO:0015198) peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.7 | 2.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.7 | 8.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.7 | 3.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.7 | 2.6 | GO:0019862 | IgA binding(GO:0019862) |
0.7 | 8.6 | GO:0031432 | titin binding(GO:0031432) |
0.7 | 9.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.7 | 2.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.7 | 2.0 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.7 | 5.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.6 | 2.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.6 | 4.5 | GO:0043426 | MRF binding(GO:0043426) |
0.6 | 2.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 1.9 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.6 | 4.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.6 | 6.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.6 | 6.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 12.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 5.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 3.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 1.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.6 | 8.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 8.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.6 | 1.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.6 | 6.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 4.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 3.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.6 | 1.8 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.6 | 5.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.6 | 5.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.6 | 1.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.6 | 3.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.6 | 4.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.6 | 11.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.6 | 19.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.6 | 2.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 1.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 15.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 8.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.6 | 3.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 6.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.6 | 2.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.6 | 2.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.6 | 1.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 3.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.6 | 4.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 2.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.6 | 3.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 2.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 3.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.6 | 3.9 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.5 | 11.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.5 | 2.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.5 | 4.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 3.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.5 | 2.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.5 | 1.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 2.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 5.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 1.6 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.5 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 13.2 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 16.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 1.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.5 | 11.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 1.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.5 | 2.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 2.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.5 | 6.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.5 | 14.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 1.5 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.5 | 2.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 22.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.5 | 24.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 4.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 1.5 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.5 | 0.5 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.5 | 6.0 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.5 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 1.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.5 | 1.5 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.5 | 1.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.5 | 1.5 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.5 | 20.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 1.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 1.4 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.5 | 28.6 | GO:0019905 | syntaxin binding(GO:0019905) |
0.5 | 1.9 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.5 | 1.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.5 | 5.7 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.5 | 2.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.5 | 10.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.5 | 2.8 | GO:0005119 | smoothened binding(GO:0005119) |
0.5 | 3.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.5 | 5.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 11.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 3.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 3.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.5 | 6.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 6.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.5 | 17.8 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 3.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.5 | 0.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.5 | 31.6 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.5 | 5.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 2.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 1.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.4 | 2.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 23.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 2.7 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.4 | 0.9 | GO:0001016 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.4 | 1.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 1.8 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 6.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 3.1 | GO:0017022 | myosin binding(GO:0017022) |
0.4 | 4.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 2.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.4 | 0.9 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 6.5 | GO:0016918 | retinal binding(GO:0016918) |
0.4 | 1.7 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.4 | 7.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 1.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 17.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 5.9 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 0.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.4 | 2.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 2.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 1.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.4 | 6.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 3.7 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 2.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 6.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 10.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 1.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.4 | 4.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 2.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 4.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 6.8 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 2.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 7.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 58.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.4 | 1.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 1.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 1.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 16.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 10.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 44.5 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.4 | 1.9 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 10.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.4 | 5.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 3.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.9 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.4 | 26.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 9.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 0.7 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.4 | 2.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 1.5 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.4 | 5.5 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.4 | 4.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.4 | 36.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 5.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 8.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.4 | 1.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 3.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 2.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 2.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 7.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 1.4 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.3 | 12.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 1.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.3 | 1.0 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 2.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.3 | 3.7 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.3 | 116.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.3 | 2.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.0 | GO:0070984 | SET domain binding(GO:0070984) |
0.3 | 7.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 2.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.0 | GO:0043236 | laminin binding(GO:0043236) |
0.3 | 1.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.6 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.3 | 5.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 1.9 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.3 | 3.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 3.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 5.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 3.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 1.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.3 | 5.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 0.6 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.3 | 1.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 2.6 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.3 | 1.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 2.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 2.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 8.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 0.3 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 1.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 5.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.9 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.3 | 2.4 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 1.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 4.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 1.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.3 | 54.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 1.6 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.3 | 0.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.3 | 0.8 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.3 | 18.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.3 | 3.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.3 | 1.8 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.3 | 0.5 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.3 | 3.0 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 2.7 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 4.7 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.2 | 1.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 5.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 4.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 2.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 2.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.7 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 7.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 5.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 7.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 1.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.9 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 0.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 5.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 2.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.2 | 1.3 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.2 | 3.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 1.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 2.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 2.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 0.8 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.2 | 0.8 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 1.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 2.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.6 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.2 | 1.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 2.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 5.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 3.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 1.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 2.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 10.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 3.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 0.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.2 | 0.9 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.7 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 1.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 3.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 2.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.7 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.2 | 1.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.8 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.2 | 2.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 2.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 2.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 1.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 2.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.2 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 2.7 | GO:0005516 | calmodulin binding(GO:0005516) |
0.2 | 1.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 1.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 3.3 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 1.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 5.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 3.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.7 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 0.6 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.7 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 1.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 10.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.4 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 6.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.4 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 2.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 2.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 2.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.2 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.1 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 72.4 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 1.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 1.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.4 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.2 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 2.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 1.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.3 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.0 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 1.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 1.4 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.0 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.0 | GO:0015350 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 3.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
2.7 | 58.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.7 | 3.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.3 | 6.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.1 | 25.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.1 | 55.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.1 | 53.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.0 | 15.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.0 | 35.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.0 | 16.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.9 | 64.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.9 | 28.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.8 | 45.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.8 | 3.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.7 | 4.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.7 | 3.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 6.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 17.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.7 | 10.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.7 | 2.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 15.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 47.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 10.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 15.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 23.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 3.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.6 | 3.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.6 | 3.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 7.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.5 | 12.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.5 | 13.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 23.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 22.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.5 | 12.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.5 | 5.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 2.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 5.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 8.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 10.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 6.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 6.5 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 2.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 4.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 5.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 15.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 11.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 6.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 8.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 3.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 1.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 7.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 13.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 6.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 4.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 3.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 11.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 11.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 5.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 46.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 11.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 5.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 24.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 1.3 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 13.9 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 5.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 2.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 11.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 3.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 29.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 8.3 | PID ATM PATHWAY | ATM pathway |
0.2 | 78.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 2.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 4.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 3.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 49.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 8.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 17.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 5.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 4.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 8.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 4.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 4.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 5.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 3.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 73.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
4.1 | 8.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
3.9 | 90.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
3.3 | 16.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.7 | 3.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
1.7 | 10.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.7 | 40.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.6 | 19.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.6 | 14.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.5 | 48.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.5 | 29.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.4 | 25.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
1.4 | 68.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.4 | 1.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.3 | 19.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.3 | 19.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
1.2 | 11.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.2 | 35.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.1 | 29.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.1 | 3.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.0 | 6.3 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
1.0 | 43.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.0 | 29.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.0 | 14.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.0 | 13.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.0 | 4.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.0 | 2.9 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
1.0 | 4.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.9 | 27.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.9 | 2.7 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.9 | 36.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.9 | 4.4 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.9 | 12.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.9 | 29.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.8 | 14.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.8 | 20.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 17.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.8 | 11.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.8 | 21.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.8 | 16.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.8 | 1.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.8 | 3.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.8 | 35.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 9.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.7 | 5.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 34.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.7 | 41.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 8.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.7 | 10.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.7 | 35.9 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.6 | 3.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.6 | 8.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 5.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 11.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 11.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.6 | 17.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 11.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.6 | 20.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 45.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 9.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 11.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 1.0 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.5 | 1.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.5 | 8.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 85.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 24.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.5 | 2.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 4.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 6.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 17.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 8.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 13.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 8.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.4 | 2.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 56.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.4 | 8.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 1.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.4 | 6.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 2.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.4 | 11.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 19.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 6.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 1.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 5.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 2.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.4 | 4.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 8.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 4.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 3.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 11.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 1.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 1.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 9.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 10.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.3 | 17.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 2.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 5.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 4.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 7.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 3.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 27.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 10.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 5.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 5.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 10.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 4.6 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.3 | 93.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 4.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 6.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 5.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 9.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 3.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 4.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 3.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 3.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 3.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 3.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 2.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 3.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 2.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 5.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 3.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 5.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 5.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 2.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 5.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 0.2 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.2 | 5.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 3.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 3.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 7.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 4.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.9 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 1.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |